NCT04247217View on ClinicalTrials.gov

Immune Profiling After HDR in Local Relapsed Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

February 19, 2020

Primary Completion Date

December 23, 2021

Study Completion Date

December 23, 2021

Conditions
Prostate CancerPD-L1
Interventions
RADIATION

HDR salvage brachytherapy

In patients receiving HDR salvage brachytherapy for locally relapsed prostate cancer serial biopsies will be performed at 4 different time points.

Trial Locations (1)

6229 ET

Maastro, Maastricht

All Listed Sponsors
lead

Maastricht Radiation Oncology

OTHER

NCT04247217 - Immune Profiling After HDR in Local Relapsed Prostate Cancer | Biotech Hunter | Biotech Hunter